-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q3 2023.
- Orchard Therapeutics plc Interest Expense for the quarter ending September 30, 2023 was $932K, a 16.6% increase year-over-year.
- Orchard Therapeutics plc Interest Expense for the twelve months ending September 30, 2023 was $3.8M, a 34.2% increase year-over-year.
- Orchard Therapeutics plc annual Interest Expense for 2022 was $3.08M, a 23.3% increase from 2021.
- Orchard Therapeutics plc annual Interest Expense for 2021 was $2.5M, a 7.26% increase from 2020.
- Orchard Therapeutics plc annual Interest Expense for 2020 was $2.33M, a 51.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)